While respiratory syncytial virus (RSV) typically causes mild symptoms in adults, the virus can be life-threatening for infants. The seasonal virus is the most common cause of lower respiratory tract ...

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

Recent studies have shown convincingly that vaccines against shingles (Herpes zoster) reduce the risk of dementia.

A prominent paediatrician on Sunday urged people to take more precautions against a common virus known as RSV, saying cases ...

Protection against RSV derived from preF IgG antibodies waned 6 months after infection in an analysis of patients with confirmed disease and household contacts.

Kennedy’s controversial panel overhaul met its first test. The result? A major win for public health ahead of RSV season.

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review standards.

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9.

U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisory committee is meeting for a second day in a row. On ...

A new study shows that a vaccine against respiratory syncytial virus is associated with a 29% reduction in dementia risk in ...